AIM held eight listening sessions with immunization program managers (PMs) during the Vaccine Access Cooperative (VAC) Regional Meetings for adult immunization from May-July 2024. The goal of these listening sessions was to understand the successes and challenges jurisdictions and immunization programs (IPs) experienced with COVID-19 vaccination in children ages 11 years and younger post COVID-19 vaccine commercialization. These listening sessions were conducted in the spring and summer 2024 following COVID-19 commercialization. The report summarizes the findings from the eight listening sessions.
COVID-19 Pediatric Vaccination Commercialization Listening Sessions Report
Related Items
Request for Interest Forms: Community of Practice to Optimize Administration of Birth Dose Immunizations
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.
Immunization and Maternal Child Health Programs: Ideas for Partnering to Protect Women and Children
Explore AIM’s one-pager about collaboration opportunities between immunization programs (IPs) and maternal child health (MCH) programs.
Pediatric Vaccination Media Assets
AIM partnered with CDC and CommunicateHealth, Inc. to create a media library of free co-brandable assets encouraging infant vaccination.